SCHEMBL5267660

SCHEMBL5267660

COc1ccc(-c2nc(C(=O)O)[nH]c2-c2ccc(OC)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.62
KMT2A Q03164 6/20 0.62
ALDH1A1 P00352 6/20 0.62
MEN1 O00255 5/20 0.62
KDM4E B2RXH2 5/20 0.62
HPGD P15428 4/20 0.62
GAA P10253 4/20 0.62
GLA P06280 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2C19 P33261 1/20 0.62
GFER P55789 1/20 0.62
NOX1 Q9Y5S8 1/20 0.57
TP53 P04637 2/20 0.56
MAPK13 O15264 2/20 0.52
MAPK12 P53778 2/20 0.52
MAPK11 Q15759 2/20 0.52
MAPK14 Q16539 2/20 0.52
SMPD3 Q9NY59 1/20 0.52
RAF1 P04049 1/20 0.52
LMNA P02545 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11170965 0.83 NOX1 (0.52) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL11184970 0.81 NOX1 (0.50) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL5274289 0.80 KDM4E (0.58) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL5268736 0.80 CNR1 (0.58) KMT2AALDH1A1MEN1KDM4EHPGD
SCHEMBL10921523 0.78 MAPT (0.55) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL10717261 0.78 MAPT (0.52) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL11073588 0.77 MAPT (0.54) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL10799922 0.77 MAPT (0.54) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL10920022 0.77 MAPT (0.54) MAPTKMT2AALDH1A1MEN1KDM4E
SCHEMBL3455232 0.77 NOX1 (0.77) MAPTKMT2AALDH1A1MEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844020-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS Exelixis, Inc. (US) 2007-10-17 EP claimed
WO-2007024744-A2 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS, INC. (US) 2007-03-01 WO claimed
WO-2006076202-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTORS LIGANDS EXELIXIS, INC. (US) 2006-07-20 WO claimed
EP-1844020-B1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS INC (US) 2017-09-06 EP disclosed
EP-1844020-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS Exelixis, Inc. (US) 2007-10-17 EP disclosed
WO-2007024744-A2 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTOR LIGANDS EXELIXIS, INC. (US) 2007-03-01 WO disclosed
WO-2006076202-A1 HETEROCYCLIC CARBOXAMIDE COMPOUNDS AS STEROID NUCLEAR RECEPTORS LIGANDS EXELIXIS, INC. (US) 2006-07-20 WO disclosed